While these combined genetic and epigenetic findings strongly indicate that CFTR expression levels constitute a strong biomarker for lung cancer outcomes, they do not provide information about whether suppression of CFTR is a consequence of cellular transformation or might act as an upstream driver. Here, CFTR is linked to lung cancer.